Leishmania amazonensis exhibits phosphatidylserine-dependent procoagulant activity, a process that is counteracted by sandfly saliva

Memorias do Instituto Oswaldo Cruz

Volumn 108, Issue 6, 2013, Pages 679-685

  Cadaxo Rochael, Natalia ^a   Lima, Luize Gonçalves ^a   de Oliveira, Sandra Maria Pereira ^b   Barcinski, Marcello André ^c   Saraiva, Elvira Maria ^a   Monteiro, Robson Queiroz ^a   Pinto da Silva, Lucia Helena ^d  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Departamento de Entomologia   (Brazil)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

^d FEDERAL RURAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Blood coagulation; Leishmania amazonensis; Lutzomyia longipalpis; Phosphatidylserine; Sandfly saliva

Indexed keywords

ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 5; CANCER PROCOAGULANT; CYSTEINE PROTEINASE; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLSERINE; PROTHROMBINASE COMPLEX; THROMBIN; TISSUE EXTRACT; TUMOR PROTEIN;

ANIMAL; ARTICLE; BLOOD CLOTTING; DISEASE CARRIER; DRUG ANTAGONISM; HUMAN; LEISHMANIA; METABOLISM; PARASITOLOGY; PARTIAL THROMBOPLASTIN TIME; PHYSIOLOGY; PSYCHODIDAE; SALIVA;

ANIMALS; ANTICOAGULANTS; BLOOD COAGULATION; CYSTEINE ENDOPEPTIDASES; FACTOR V; FACTOR X; FACTOR XA; HUMANS; INSECT VECTORS; LEISHMANIA; NEOPLASM PROTEINS; PARTIAL THROMBOPLASTIN TIME; PHOSPHATIDYLCHOLINES; PHOSPHATIDYLSERINES; PSYCHODIDAE; SALIVA; THROMBIN; TISSUE EXTRACTS;

EID: 84883706013     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/0074-0276108062013002     Document Type: Article

References (42)

1. Astermark J, Hogg PJ, Bjork I, Stenflo J 1992. Effects of gamma-carboxyglutamic acid and epidermal growth fator-like modules of factor IX on factor X activation. Studies using proteolytic fragments of bovine factor IX. J Biol Chem 267: 3249-3256.
2. Balanco JMF, Moreira ME, Bonomo A, Bozza PT, Amarante-Mendes G, Pirmez C, Barcinski M 2001. Apoptotic mimicry by an obligate intracellular parasite downregulates macrophage microbicidal activity. Curr Biol 11: 1870-1873.
3. Calvo E, Mizurini DM, Sá-Nunes A, Ribeiro JM, Andersen JF, Mans BJ, Monteiro RQ, Kotsyfakis M, Francischetti IM 2011. Alboserpin, a factor Xa inhibitor from the mosquito vector of yellow fever, binds heparin and membrane phospholipids and exhibits antithrombotic activity. J Biol Chem 286: 27998-28010.
4. Champagne DE 2005. Antihemostatic molecules from saliva of blood-feeding arthropods. Pathophysiol Haemost Thromb 34: 221-227.
5. Charlab R, Valenzuela JG, Rowton ED, Ribeiro JM 1999. Toward an understanding of the biochemical and pharmacological complexity of the saliva of haematophagous sandfly Lutzomyia longipalpis. Proc Natl Acad Sci USA 96: 15155-15160.
6. Collin N, Assumpção TC, Mizurini DM, Gilmore DC, Dutra-Oliveira A, Kotsyfakis M, Sá-Nunes A, Teixeira C, Ribeiro JM, Monteiro RQ, Valenzuela JG, Francischetti IM 2012. Lufaxin, a novel factor Xa inhibitor from the salivary gland of the sandfly Lutzomyia longipalpis blocks protease-activated receptor 2 activation and inhibits inflammation and thrombosis in vivo. Arterioscler Thromb Vasc Biol 32: 2185-2198.
7. Farias LHS, Rodrigues APD, Silveira FT, Seabra SH, DaMatta RA, Saraiva EM, Silva EO 2013. Phosphatidylserine exposure and surface sugars in two Leishmania (Viannia) braziliensis strains involved in cutaneous and mucocutaneous leishmaniasis. J Infect Dis 207: 537-543.
8. Fernandes RS, Kirszberg C, Rumjanek VM, Monteiro RQ 2006. On the molecular mechanisms for the highly procoagulant pattern of C6 glioma cells. J Thromb Haemost 4: 1546-1552.
9. França-Costa J, Wanderley JL, Deolindo P, Zarattini JB, Costa J, Soong L, Barcinski MA, Barral A, Borges VM 2012. Exposure of phosphatidylserine on Leishmania amazonensis isolates is associated with diffuse cutaneous leishmaniasis and parasite infectivity. PLoS ONE 7: e36595.
10. Francischetti IM, Seydel KB, Monteiro RQ, Whitten RO, Erexson CR, Noronha AL, Ostera GR, Kamiza SB, Molyneux ME, Ward JM, Taylor TE 2007. Plasmodium falciparum-infected erythrocytes induce tissue factor expression in endothelial cells and support the assembly of multimolecular coagulation complexes. J Thromb Haemost 5: 155-165.
11. Francischetti IM, Valenzuela JG, Ribeiro JM 1999. Anophelin: kinetics and mechanism of thrombin inhibition. Biochemistry 38: 16678-16685.
12. Heemskerk JW, Bevers EM, Lindhout T 2002. Platelet activation and blood coagulation. Thromb Haemost 88: 186-193.
13. Henriques C, Atella GC, Bonilha VL, de Souza W 2003. Biochemical analysis of proteins and lipids found in parasitophorous vacuoles containing Leishmania amazonensis. Parasitol Res 89: 123-133.
14. Kimblin N, Peters N, Debrabant A, Secundino N, Egen J, Lawyer P, Fay MP, Kamhawi S, Sacks D 2008. Quantification of the infectious dose of Leishmania major transmitted to the skin by single sandflies. Proc Natl Acad Sci USA 105: 10125-10130.
15. Kini RM 2006. Anticoagulant proteins from snake venoms: structure, function and mechanism. Biochem J 397: 377-387.
16. Kirszberg C, Lima LG, de Oliveira AS, Pickering W, Gray E, Barrowcliffe TW, Rumjanek VM, Monteiro RQ 2009. Simultaneous tissue factor expression and phosphatidylserine exposure account for the highly procoagulant pattern of melanoma cell lines. Melanoma Res 19: 301-308.
17. Koh CY, Kini RM 2009. Molecular diversity of anticoagulants from haematophagous animals. Thromb Haemost 102: 437-453.
18. Laliberte JP, Moss B 2009. Appraising the apoptotic mimicry model and the role of phospholipids for poxvirus entry. Proc Natl Acad Sci USA 106: 17517-17521.
19. Lentz BR 2003. Exposure of platelet membrane phosphatidylserine regulates blood coagulation. Prog Lipid Res 42: 423-438.
20. Lima LG, Oliveira AS, Campos LC, Bonamino M, Chammas R, Werneck C, Vicente CP, Barcinski MA, Petersen LC, Monteiro RQ 2011. Malignant transformation in melanocytes is associated with increased production of procoagulant microvesicles. Thromb Haemost 106: 712-723.
21. Mann KG 1999. Biochemistry and physiology of blood coagulation. Thromb Haemost 82: 165-174.
22. Mercer J, Helenius A 2008. Vaccinia virus uses macropinocytosis and apoptotic mimicry to enter host cells. Science 320: 531-535.
23. Monteiro RQ 2005. Targeting exosites on blood coagulation proteases. An Acad Bras Cienc 77: 275-280.
24. Pérez de León AA, Valenzuela JG, Tabachnick WJ 1998. Anticoagulant activity in salivary glands of the insect vector Culicoides variipennis sonorensis by an inhibitor of factor Xa. Exp Parasitol 88: 121-130.
25. Rana T, Misra S, Mittal MK, Farrow AL, Wilson KT, Linton MF, Fazio S, Willis IM, Chaudhuri G 2011. Mechanism of down-regulation of RNA polymerase III-transcribed non-coding RNA genes in macrophages by Leishmania. J Biol Chem 286: 6614-6626.
26. Ribeiro JM, Francischetti IM 2003. Role of arthropod saliva in blood feeding: sialome and post-sialome perspectives. Annu Rev Entomol 48: 73-88.
27. Santos TA, Portes JA, Damasceno-Sá JC, Caldas LA, Souza WD, DaMatta RA, Seabra SH 2011. Phosphatidylserine exposure by Toxoplasma gondii is fundamental to balance the immune response granting survival of the parasite and of the host. PLoS ONE 6: e27867.
28. Secundino NF, de Freitas VC, Monteiro CC, Pires AC, David BA, Pimenta PF 2012. The transmission of Leishmania infantum chagasi by the bite of the Lutzomyia longipalpis to two different vertebrates. Parasite Vectors 5: 20.
29. Späth GF, Beverley SM 2001. A lipophosphoglycan-independent method for isolation of infective Leishmania metacyclic promastigotes by density gradient centrifugation. Exp Parasitol 99: 97-103.
30. Stark KR, James AA 1996. Salivary gland anticoagulants in culicine and anopheline mosquitoes (Diptera: Culicidae). J Med Entomol 33: 645-650.
31. Valenzuela JG, Garfield M, Rowton ED, Pham VM 2004. Identification of the most abundant secreted proteins from the salivary glands of the sandfly Lutzomyia longipalpis, vector of Leishmania chagasi. J Exp Biol 207: 3717-3729.
32. van Zandbergen G, Bollinger A, Wenzel A, Kamhawi S, Voll R, Klinger M, Müller A, Hölsch C, Herrmann M, Sacks D, Solbach W, Laskay T 2006. Leishmania disease development depends on the presence of apoptotic promastigotes in the virulent inoculum. Proc Natl Acad Sci USA 103: 13837-13842.
33. Wanderley JL, Barcinski MA 2010. Apoptosis and apoptotic mimicry: the Leishmania connection. Cell Mol Life Sci 67: 1653-1659.
34. Wanderley JL, da Silva LHP, Deolindo P, Soong L, Borges VM, Prates DB, de Souza AP, Barral A, Balanco JM, do Nascimento MT, Saraiva EM, Barcinski MA 2009. Cooperation between apoptotic and viable metacyclics enhances the pathogenesis of leishmaniasis. PLoS ONE 4: e5733.
35. Wanderley JL, Moreira ME, Benjamin A, Bonomo AC, Barcinski MA 2006. Mimicry of apoptotic cells by exposing phosphatidylserine participates in the establishment of amastigotes of Leishmania (L.) amazonensis in mammalian hosts. J Immunol 176: 1834-1839.
36. Wassef MK, Fioretti TB, Dwyer DM 1985. Lipid analyses of isolated surface membranes of Leishmania donovani promastigotes. Lipids 20: 108-115.
37. Watanabe RM, Tanaka-Azevedo AM, Araujo MS, Juliano MA, Tanaka AS 2011. Characterization of thrombin inhibitory mechanism of rAaTI, a Kazal-type inhibitor from Aedes aegypti with anticoagulant activity. Biochimie 93: 18-23.
38. Weingärtner A, Kemmer G, Müller FD, Zampieri RA, dos Santos MG, Schiller J, Pomorski TG 2012. Leishmania promastigotes lack phosphatidylserine, but bind annexin V upon permeabilization or miltefosine treatment. PLoS ONE 7: e42070.
39. Yoneyama KA, Tanaka AK, Silveira TG, Takahasha HK, Straus AH 2006. Characterization of Leishmania (Viannia) braziliensis membrane microdomains and their role in macrophage infectivity. J Lipid Res 47: 2171-2178.
40. Zhang K, Pompey JM, Hsu FF, Key P, Bandhuvula P, Saba JD, Turk J, Beverley SM 2007. Redirection of sphingolipid metabolism toward de novo synthesis of ethanolamine in Leishmania. EMBO J 26: 1094-1104.
41. Zheng L, T'Kind R, Decuypere S, von Freyend SJ, Coombs GH, Watson DG 2010. Profiling of lipids in Leishmania donovani using hydrophilic interaction chromatography in combination with Fourier transform mass spectrometry. Rapid Commun Mass Spectrom 24: 2074-2082.
42. Zufferey R, Allen S, Barron T, Sullivan DR, Denny PW, Almeida C, Smith DF, Turco SJ, Ferguson MA, Beverley SM 2003. Ether phospholipids and glycosylinositol phospholipids are not required for amastigote virulence or for inhibition of macrophage activation by Leishmania major. J Biol Chem 278: 44708-44718.